NY double-teams Merck in Vioxx lawsuit

Buy more stock in Merck's law firm: New York State and New York City have sued the company to recoup more than $100 million they spent on the drug, joining six other states suing on behalf of their Medicaid plans.

The suit mimics other claims against the company: that Merck intentionally concealed the bad news about Vioxx, thus inducing the state's Medicaid program to pay for a drug Merck knew could be dangerous. Merck's lawyers deny the claims, saying the company acted responsibly, and vowing--as is its habit--to vigorously defend itself.

- read the statement from NY Attorney General Andrew Cuomo
- see this article from The New York Times

Suggested Articles

Novavax has inked a $60 million contract with the U.S. Department of Defense to help fund U.S.-based manufacturing of its COVID-19 vaccine candidate.

Since the Warp Speed selections went public, experts have been wondering why some drugmakers were left off.

Vaccine maker Inovio has accused a longtime manufacturing partner of hampering its efforts to produce 1 million doses of a potential COVID-19 vaccine.